Literature DB >> 10065757

Interleukin-4 and interferon-gamma inhibit prostaglandin production by interleukin-1beta-stimulated human periodontal ligament fibroblasts.

K Noguchi1, M Shitashige, H Watanabe, S Murota, I Ishikawa.   

Abstract

The purpose of the present study was to investigate the involvement of cyclooxygease-1 (COX-1) and cyclooxygenase-2 (COX-2) in prostaglandin (PG) production by human periodontal ligament (PDL) fibroblasts stimulated with a proinflammatory cytokine, inerleukin-1beta (IL-1beta), and to examine the effect of interleukin-4 (IL-4), a Th2 cytokine, and interferon-gamma (IFN-gamma), a Th1 cytokine, on PG production by the cells. IL-1beta-stimulated PDL fibroblasts produced prostaglandin E2 (PGE2) in a time-dependent manner. Indomethacin, a non-selective COX-1/COX-2 inhibitor, and NS-398, a selective COX-2 inhibitor, completely inhibited PGE2 production by IL-1beta-stimulated cells. Northern blot analysis showed that COX-2 mRNA was detected in IL-1beta-stimulated PDL cells, although not detected in unstimulated cells, while expression of COX-1 mRNA was in the same extent in both the cells. Dexamethasone inhibited COX-2 mRNA expression, COX activity and PGE2 production in IL-1beta-stimulated cells. IL-4 and IFN-gamma suppressed PGE2 production by IL-1beta-stimulated PDL fibroblasts, but COX activity enhanced by IL-1beta treatment was significantly inhibited by IL-4, not by IFN-gamma. Northern blot analysis showed that IL-4 depressed COX-2 mRNA expression with no effect on COX-1 mRNA expression. On the other hand, IFN-gamma had no effect on expression of COX-1 and -2 mRNA. These data suggest that COX-2 is primarily responsible for PGE2 production by IL-1beta-stimulated human PDL fibroblasts and that IL-4 inhibited PGE2 production by IL-1beta-stimulated PDL fibroblasts through down-regulation of COX-2 expression, while IFN-gamma suppressed the PGE2 production with no effect on COX-2 expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10065757     DOI: 10.1023/a:1020231331932

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  50 in total

1.  Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide.

Authors:  S H Lee; E Soyoola; P Chanmugam; S Hart; W Sun; H Zhong; S Liou; D Simmons; D Hwang
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

2.  Interleukin 4 inhibits murine osteoclast formation in vitro.

Authors:  A Shioi; S L Teitelbaum; F P Ross; H G Welgus; H Suzuki; J Ohara; D L Lacey
Journal:  J Cell Biochem       Date:  1991-11       Impact factor: 4.429

Review 3.  Modulation of host PGE2 secretion as a determinant of periodontal disease expression.

Authors:  S Offenbacher; P A Heasman; J G Collins
Journal:  J Periodontol       Date:  1993-05       Impact factor: 6.993

4.  Role of the osteoclast in prostaglandin E2-stimulated bone resorption: a correlative morphometric and biochemical analysis.

Authors:  S H Schelling; H J Wolfe; A H Tashjian
Journal:  Lab Invest       Date:  1980-03       Impact factor: 5.662

5.  Fibroblastic cells derived from bovine periodontal ligaments have the phenotypes of osteoblasts.

Authors:  N Nojima; M Kobayashi; M Shionome; N Takahashi; T Suda; K Hasegawa
Journal:  J Periodontal Res       Date:  1990-05       Impact factor: 4.419

6.  Human cyclooxygenase-2 cDNA.

Authors:  T Hla; K Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  Multiple second messenger pathways regulate IL-1 beta-induced expression of PGHS-2 mRNA in normal human skin fibroblasts.

Authors:  L J Warnock; G W Hunninghake
Journal:  J Cell Physiol       Date:  1995-04       Impact factor: 6.384

8.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.

Authors:  D A Jones; D P Carlton; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

9.  Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes.

Authors:  M L Corcoran; W G Stetler-Stevenson; P D Brown; L M Wahl
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

10.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01
View more
  6 in total

1.  Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2/EP4 receptors by prostaglandin E2 in human fibroblasts.

Authors:  K Noguchi; K Iwasaki; M Shitashige; M Umeda; Y Izumi; S Murota; I Ishikawa
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

2.  Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts.

Authors:  K-H Hong; M-L Cho; S-Y Min; Y-J Shin; S-A Yoo; J-J Choi; W-U Kim; S-W Song; C-S Cho
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

3.  Prostaglandin E2 downregulates interferon-gamma-induced intercellular adhesion molecule-1 expression via EP2 receptors in human gingival fibroblasts.

Authors:  K Noguchi; K Iwasaki; M Shitashige; S Murato; I Ishikawa
Journal:  Inflammation       Date:  1999-10       Impact factor: 4.092

Review 4.  Regulation of T helper cell subsets by cyclooxygenases and their metabolites.

Authors:  Hong Li; Matthew L Edin; Artiom Gruzdev; Jennifer Cheng; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-11-28       Impact factor: 3.072

5.  Resolvin D1 protects periodontal ligament.

Authors:  Manal Mustafa; Ahmed Zarrough; Anne Isine Bolstad; Henning Lygre; Kamal Mustafa; Hatice Hasturk; Charles Serhan; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-17       Impact factor: 4.249

Review 6.  Regulation of inflammation by lipid mediators in oral diseases.

Authors:  S Sommakia; O J Baker
Journal:  Oral Dis       Date:  2016-08-04       Impact factor: 3.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.